Sponsored Links

Glowing Cornell Dots - A Potential Cancer Diagnostic Tool Set For Human Trials PDF Print E-mail
Medical News - Cancer Oncology
The U.S. Food and Drug Administration (FDA) has approved the first clinical trial in humans of a new technology: Cornell Dots, brightly glowing nanoparticles that can light up cancer cells in PET-optical imaging...

Read more: Cancer / Oncology News From Medical News Today